ASSESS YOUR DVT RISK >
The World’s first truly portable FDA Cleared Device Designed to help prevent post-operative DVT.
VenaPro™ Increases patient safety by decreasing the incidence of deep vein thrombosis (DVT) and related pulmonary embolism (PE), which together affect more than two million Americans every year. In fact, DVT causes more than 300,000 deaths annually
VenaPro™ Vascular Therapy System was designed to be a minimal, portable device conveintly powered by rechargeable batteries. VenaPro is intended to be used in the home or clinical setting under the direction of a medical professional to help stimulate blood flow as an aid in the prevention of deep vein thrombosis (DVT).
VenaPro™ was designed to be lightweight. Each unit weighs less than 1 pound. VenaPro has also been designed with Cool Care Releasing Technology (CCRT) to draw moisture away from the leg helping to keep the leg cool and increase comfort and ease of use.
VenaPro™ provides sequential, asymmetrical, gradient, graduated compression distal to proximal, duplicating the blood flow of an ambulating patient. VenaPro helps prevent dangerous blood clots deep inside the leg, during and post-surgery with its pre-set pressure cycle. VenaPro is self-contained and allows better compliance with increased portability.
Easy Touch Operation
The risks of DVT have been defined and quantified, and the ability to lessen the problem by use of prophylactic measures has been shown in a number of studies. – 80% of PE occurs without signs. The statistics prove that this is a problem that is far greater than is realized. VenaPro™ provides a continuum of care from the facility to the outpatient setting with its self-contained single patient use design.